Astellas Pharma Balance Sheet - Quarterly (OTCMKTS:ALPMY)

Add to My Stocks
$17.81 $0.31 (1.77%) ALPMY stock closing price Sep 19, 2018 (Closing)

The financial analysis of a company involves interpreting the income statement, balance sheet and cash flow statements of the company to draw insights like we've done in our Astellas Pharma stock analysis. All three financial statements should be used to measure the financial performance of the company, and should form a part of the Astellas Pharma stock analysis. Quarterly results are typically accompanied with the company releasing financial statements. Astellas Pharma had a long term debt of $- at the end of 2019 Q1. To understand the debt servicing capacity of the company, one needs to look at Astellas Pharma operating cash flow and Astellas Pharma revenue also. Astellas Pharma debt to equity ratio is 0.05.

View and download Astellas Pharma quarterly results to get the balance sheet details for the latest 40 quarters data.
show more
View Previous Quarters
View Next Quarters
Fiscal year is Apr - Mar2019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q4
Marketable Securities218.06M121.65M547.78M427.27M288.77M121M208.52M117.42M118.35M119.47M
Raw Materials----------
Work In Progress----------
Finished Goods----------
Notes Receivable----------
Other Current Assets159.91M223.39M240.78M251.55M180.64M168M163.54M165.1M154.6M144.59M
Total Current Assets
Property Plant & Equipment----------
Accumulated Depreciation----------
Net Property Plant & Equipment
Investment & Advances781.19M634.61M656.87M693.1M565.26M577M680.53M836.34M775.71M762.42M
Other Non-Current Assets235.44M227.53M212.3M213.74M210.93M199M268.05M274.5M247.37M200.05M
Deferred Charges875.88M875.13M856.82M898.56M853.72M807M729.97M727.13M743.81M666.09M
Deposits & Other Assets74.55M75.34M87.22M87.99M109.04M117M130.83M129.62M123.63M122.58M
Total Assets
Notes Payable----------
Accounts Payable1.27B1.27B1.23B1.13B1.37B1.63B1.49B1.51B1.48B1.51B
Current Portion Long-Term Debt----------
Current Portion Capital Leases170.39M68.03M60.64M24.88M35.55M27M80.4M338.68M339.31M12.49M
Accrued Expenses----------
Income Taxes Payable202.23M226.65M154.13M137.96M144.33M97M136.86M94.84M84.77M160.28M
Other Current Liabilities2.39B2.23B2.08B2B2.06B1.81B1.97B1.81B1.79B1.75B
Total Current Liabilities
Deferred Taxes/Income203.32M237.83M347.45M416.01M400.67M226M172.85M---
Convertible Debt----------
Long-Term Debt----------
Non-Current Capital Leases411.42M444.79M-314.61M303.53M253M171.27M7.98M7.7M5.99M
Other Long-Term Liabilities783.5M832.04M1.18B884.06M920.61M853M946.86M995.54M983.02M1.05B
Total Liabilities
Minority Interest----------
Preferred Stock----------
Common Stock Net947.61M927M916.7M927M927M920M947.6M1.01B957.9M854.9M
Capital Surplus1.63B1.59B1.58B1.59B1.59B1.58B1.63B1.73B1.65B1.47B
Retained Earnings7.96B8.78B8.5B8.37B8.01B9.05B8.93B9.22B8.31B8.08B
Treasury Stock303.4M1.22B676.8M499.95M58.13M1.23B856.86M463.95M440.86M1.3B
Other Liabilities1.51B1.33B1.85B1.76B1.4B1.04B1.43B523.28M596.77M1.36B
Shareholders Equity11.74B11.41B12.17B12.16B11.88B11.36B12.08B12.03B11.07B10.45B
Total Liabilities & Shareholders Equity17.17B16.72B17.21B17.06B17.11B16.26B17.06B16.79B15.75B14.93B
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

The latest Astellas Pharma stock price, and Astellas Pharma historical stock prices show the stock price movement over time, and the Astellas Pharma PE ratio chart displays the PE ratio movement. Apart from stock price, one should also look at balance sheet items which mainly comprise of the following:

  • Assets: An asset is a resource that a corporation like Astellas Pharma owns and has economic value. The two major types of assets are: fixed assets like real estate, plant and machinery and current assets like cash, marketable securities and inventory. The total asset value for ALPMY stock as of 2019 Q1 is $17.17B. Its easy to associate the term with manufacturing companies, which invest a lot in factories and equipment. However, the same cannot be said about tech stocks.
  • Liabilities: This item on the balance sheet implies the firm's, in this case Astellas Pharma's, legal obligations including loans, accounts payable, deferred revenue, accrued expenses and mortgages. The total liabilities for ALPMY stock stand at $5.43B.

Astellas Pharma Balance Sheet - Key Ratios

Current ratio
Debt to equity ratio
Asset turnover ratio
Receivables turnover
Price to book ratio

Quarterly Balance Sheets For ASTELLAS PHARMA UNSP ADR EACH REPR 0.25 ORD Peers

Astrazeneca balance sheet, Eisai balance sheet, Pfizer balance sheet, Shire balance sheet, Zoetis balance sheet